| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 466,174 | 400,575 | ||
| Accounts receivable | 80,702 | 104,851 | ||
| Inventory | 44,506 | 38,868 | ||
| Prepaid expenses and other current assets | 21,614 | 13,835 | ||
| Total current assets | 612,996 | 558,129 | ||
| Property, plant and equipment, gross | 373,600 | - | ||
| Less accumulated depreciation and amortization | 60,578 | - | ||
| Property, plant and equipment, net | 313,022 | 312,255 | ||
| Operating lease right-of-use assets | 5,740 | 5,818 | ||
| Restricted cash | 500 | 500 | ||
| Goodwill | 11,549 | 11,549 | ||
| Acquired intangible assets, net | 1,999 | 2,050 | ||
| Other non-current assets | 226 | 221 | ||
| Total assets | 946,032 | 890,522 | ||
| Accounts payable | 12,162 | 9,539 | ||
| Accrued expenses and other current liabilities | 56,016 | 42,490 | ||
| Current portion of long-term debt | 5,000 | - | ||
| Deferred revenue | 3,305 | 1,570 | ||
| Operating lease liabilities | 3,238 | 3,021 | ||
| Total current liabilities | 79,721 | 56,620 | ||
| Convertible senior notes, net | 452,082 | 451,364 | ||
| Long-term debt, net | 54,603 | 59,525 | ||
| Operating lease liabilities, net of current portion | 4,426 | 4,912 | ||
| Preferred stock, no par value 25,000,000 shares authorized no shares issued or outstanding | - | 0 | ||
| Total liabilities | 590,832 | 572,421 | ||
| Common stock, no par value 150,000,000 shares authorized 34,144,976 shares and 33,617,972 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 738,432 | 725,655 | ||
| Accumulated other comprehensive income (loss) | 101 | 98 | ||
| Accumulated deficit | -383,333 | -407,652 | ||
| Total stockholders' equity | 355,200 | 318,101 | ||
| Total liabilities and stockholders' equity | 946,032 | 890,522 | ||
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)